These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3224610)

  • 1. An up-dating on oncologic colpocytology.
    Gentile G
    Eur J Gynaecol Oncol; 1988; 9(5):399-403. PubMed ID: 3224610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescents with abnormal cervical cytology.
    Schydlower M; Greeenberg H; Patterson PH
    Clin Pediatr (Phila); 1981 Nov; 20(11):723-6. PubMed ID: 7297012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immediate and deferred colposcopy in a cervical screening program.
    Parham GP; Andrews NR; Lee ML
    Obstet Gynecol; 2000 Mar; 95(3):340-4. PubMed ID: 10711540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papanicolaou smear screening and cervical cancer. What can you expect?
    Stenkvist B; Bergström R; Eklund G; Fox CH
    JAMA; 1984 Sep; 252(11):1423-6. PubMed ID: 6471269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynecological care of elderly women. Another look at Papanicolaou smear testing.
    Mandelblatt J; Gopaul I; Wistreich M
    JAMA; 1986 Jul; 256(3):367-71. PubMed ID: 3723723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? A HARNET Study.
    Slawson DC; Bennett JH; Herman JM
    J Fam Pract; 1993 Mar; 36(3):289-93. PubMed ID: 8454975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1991 cervical screening recommendations: a working group report.
    Paul C; Bagshaw S; Bonita R; Durham G; Fitzgerald NW; Jones RW; Marshall B; McAvoy BR
    N Z Med J; 1991 Jul; 104(915):291-5. PubMed ID: 1906587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papanicolaou smear screening augmented by a magnified chemiluminescent exam.
    Mann W; Lonky N; Massad S; Scotti R; Blanco J; Vasilev S
    Int J Gynaecol Obstet; 1993 Dec; 43(3):289-96. PubMed ID: 7907040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults. Results of data analysis of mass Papanicolaou screening of 796,337 women in the United States in 1981.
    Sadeghi SB; Hsieh EW; Gunn SW
    Am J Obstet Gynecol; 1984 Mar; 148(6):726-9. PubMed ID: 6702940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome.
    Adachi A; Fleming I; Burk RD; Ho GY; Klein RS
    Obstet Gynecol; 1993 Mar; 81(3):372-7. PubMed ID: 8437789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of cervical smears in a gynaecologic department after a period of ten years under the consideration of colposcopic findings(author's transl)].
    Michalzik K
    Arch Gynakol; 1975; 218(2):149-68. PubMed ID: 1174025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening. Who needs a Pap test? How often?
    Benedet JL; Murphy KJ
    Postgrad Med; 1985 Dec; 78(8):69-71, 74-6, 78-9. PubMed ID: 4070103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraepithelial neoplasia of the uterine cervix in the teenager.
    Feldman MJ; Kent DR; Pennington RL
    Cancer; 1978 Apr; 41(4):1405-8. PubMed ID: 639001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening. Past success and future challenge.
    Dewar MA; Hall K; Perchalski J
    Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papanicolaou smears in Victoria: are the wrong women being screened?
    Mitchell H; Drake M; Medley G
    Med J Aust; 1987 Dec 7-21; 147(11-12):559-60. PubMed ID: 3696044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effective policies for cervical cancer screening. An international review.
    Fahs MC; Plichta SB; Mandelblatt JS
    Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
    Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
    J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papanicolaou cervical smears for screening in asymptomatic women.
    Barnes BA
    Prim Care; 1981 Mar; 8(1):131-40. PubMed ID: 6911755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.